GALT

Galectin Therapeutics Inc. Press Releases

$5.45
*  
0.17
3.22%
Get GALT Alerts
*Delayed - data as of Oct. 30, 2014  -  Find a broker to begin trading GALT now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    GALT After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Galectin Therapeutics'' Abstract Accepted as Oral Presentation at The Liver Meeting(R), Annual Meeting of the American Association for the Study of Liver Diseases
10/1/2014 1:45:00 PM - GlobeNewswire


GALECTIN 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Securities Class Action Lawsuit Against Galectin Therapeutics Inc. - GALT
9/26/2014 10:00:00 PM - Market Wire


Galectin Therapeutics Elects Gilbert S. Omenn, M.D., Ph.D., a Leading Cancer Researcher, to Its Board of Directors
9/24/2014 8:00:00 AM - GlobeNewswire


Galectin Therapeutics Announces Issuance of U.S. Patent for GR-MD-02 in Diabetic Nephropathy
9/15/2014 8:00:00 AM - GlobeNewswire


DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Galectin Therapeutics Inc. Of Upcoming Deadline
9/12/2014 12:19:00 PM - Business Wire


Galectin Therapeutics to Present at Aegis Capital Corporation 2014 Healthcare and Technology Conference
9/10/2014 8:00:00 AM - GlobeNewswire


SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Galectin Therapeutics, Inc. and Certain Officers - GALT
9/5/2014 4:29:00 PM - PR Newswire


Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Galectin Therapeutics, Inc. (GALT) To Contact The Firm
8/29/2014 9:15:00 PM - PR Newswire


Deadline in Lawsuit for Investors in Galectin Therapeutics Inc. (GALT) Shares Over Alleged Securities Laws Violations Announced by Shareholders Foundation
8/26/2014 10:15:00 AM - GlobeNewswire


Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Galectin Therapeutics, Inc. (GALT) to Contact the Firm
8/23/2014 9:15:00 AM - Market Wire


GALECTIN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Galectin Therapeutics Inc.
8/22/2014 10:00:00 PM - Business Wire


SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investments in Galectin Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline -- GALT
8/22/2014 1:37:00 PM - GlobeNewswire


Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Galectin Therapeutics Inc.
8/22/2014 1:37:00 PM - Business Wire


Galectin Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors
8/11/2014 5:29:00 PM - Business Wire


Lifshitz & Miller Law Firm Announces Investigation of Cobalt International Energy, Inc., DreamWorks Animation SKG, Inc., Galectin Therapeutics, Inc., Impax Laboratories, Inc., Peoples Federal Bancshares, Inc. and Siuslaw Financial Group, Inc.
8/8/2014 2:15:00 PM - PR Newswire


Galectin Therapeutics Reports Second Quarter 2014 Financial Results
8/7/2014 5:30:00 PM - GlobeNewswire


SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Galectin Therapeutics, Inc. and Certain Officers -- GALT
8/7/2014 10:57:00 AM - GlobeNewswire


Lieff Cabraser Announces Class Action Litigation Against Galectin Therapeutics Inc. - GALT
8/6/2014 7:26:00 PM - Business Wire


Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Galectin Therapeutics Inc.
8/6/2014 1:30:00 PM - PR Newswire


Galectin Therapeutics Receives U.S. Patent for GR-MD-02 Composition of Matter
8/5/2014 8:00:00 AM - GlobeNewswire


Morgan & Morgan Announces That a Class Action Lawsuit Has Been Filed Against Galectin Therapeutics, Inc. - GALT
8/4/2014 12:55:00 PM - GlobeNewswire


Galectin Therapeutics Responds to Class Action Lawsuit
8/4/2014 8:00:00 AM - GlobeNewswire